#ZeeBusinessLive spoke with Mr. Himanshu Baid, MD, Polymed. He emphasized that #polymed will continue to invest in new technologies & innovations for better patient care. On guidance for FY24 #polymed targets EBITDA Margin of around 25%. #polymedicure #polymedicureshare

March 31, 20250 CommentsPoly Medicure Ltd.

#ZeeBusinessLive spoke with Mr. Himanshu Baid, MD, Polymed. He emphasized that #polymed will continue to invest in new technologies & innovations for better patient care.
On guidance for FY24 #polymed targets EBITDA Margin of around 25%.